VOTING AGREEMENTVoting Agreement • September 21st, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 21st, 2023 Company Industry JurisdictionThis Voting Agreement (this “Voting Agreement”) is being delivered on September [•], 2023 by the person or persons named on the signature pages hereto (collectively, the “Holder”), as the holder of Company Shares (as defined below) of Applied Molecular Transport Inc., a Delaware corporation (the “Company”), to Cyclo Therapeutics, Inc., a Nevada corporation (“Parent”).
VOTING AGREEMENTVoting Agreement • September 21st, 2023 • Cyclo Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 21st, 2023 Company Industry JurisdictionThis Voting Agreement (this “Voting Agreement”) is being delivered on September [•], 2023 by the person or persons named on the signature pages hereto (collectively, the “Holder”), as the holder of Company Shares (as defined below) of Applied Molecular Transport Inc., a Delaware corporation (the “Company”), to Cyclo Therapeutics, Inc., a Nevada corporation (“Parent”).
VOTING AGREEMENTVoting Agreement • September 21st, 2023 • Applied Molecular Transport Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledSeptember 21st, 2023 Company Industry JurisdictionThis Voting Agreement (this “Voting Agreement”) is being delivered on September [•], 2023 by the person or persons named on the signature pages hereto (collectively, the “Holder”), as the holder of Company Shares (as defined below) of Applied Molecular Transport Inc., a Delaware corporation (the “Company”), to Cyclo Therapeutics, Inc., a Nevada corporation (“Parent”).
VOTING AGREEMENTVoting Agreement • May 24th, 2023 • Pyxis Oncology, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 24th, 2023 Company Industry JurisdictionThis Voting Agreement (this “Voting Agreement”) is being delivered on May 23, 2023 by the person or persons named on the signature pages hereto (collectively, the “Holder”), as the holder of Company Shares (as defined below) of Apexigen, Inc., a Delaware corporation (the “Company”), to Pyxis Oncology, Inc., a Delaware corporation (“Parent”).
VOTING AGREEMENTVoting Agreement • May 24th, 2023 • Apexigen, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 24th, 2023 Company Industry JurisdictionThis Voting Agreement (this “Voting Agreement”) is being delivered on May 23, 2023 by the person or persons named on the signature pages hereto (collectively, the “Holder”), as the holder of Company Shares (as defined below) of Apexigen, Inc., a Delaware corporation (the “Company”), to Pyxis Oncology, Inc., a Delaware corporation (“Parent”).